Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Director/PDMR Shareholding

5 Apr 2018 16:22

RNS Number : 0199K
Softcat PLC
05 April 2018
 

Softcat plc (the "Company")

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities

 

 

The following notification relates to the award of nil-cost options to person discharging managerial responsibilities ("PDMR") on 4 April 2018 under the Softcat plc Long Term Incentive Plan ("LTIP").  

 

Softcat plc Long Term Incentive Plan

 

On 4 April 2018, an award of nil-cost options to acquire 66,864 shares was made to Graeme Watt, a director and PDMR. The number of shares over which the nil-cost option was awarded has been calculated by reference to the closing middle market quotation of the ordinary shares derived from the Daily Official List on the dealing day preceding the date of grant (6.73 pence). The award will vest subject to the performance conditions outlined below.

 

 

Performance Conditions and Vesting of Awards

 

These nil-cost options are subject to the rules of the LTIP and will vest depending on performance against Total Shareholder Return ("TSR") and Earnings per Share ("EPS") targets as measured over a three year performance period.

 

50% of the Award will be subject to the Company's relative TSR performance against the FTSE 250 (excluding real estate and investment trusts):

 

TSR performance % of Award vesting

Below median Nil

At median 30%

Upper quartile or above 100%

 

50% of the Award will be subject to the Company's EPS for FY 2020:

 

EPS Growth % of Award vesting

Less than 23.7 pence Nil

23.7 pence 20%

26.9 pence or above 100%

 

There will be straight line vesting between the points as outlined above.

 

The normal date of vesting for the nil-cost options outlined above will be 4 April 2021 and the last date for exercise will be 3 April 2028, with dividend equivalents payable in respect of the vesting of nil-cost options in accordance with the rules of the LTIP.

 

For further information on the LTIP, please refer to the Company's Annual Report and Accounts.

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Graeme Watt

 

2.

Reason for the notification

a)

Position / status

Chief Executive

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Softcat plc

b)

LEI

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of £0.0005 each

 

 

ISIN: GB00BYZDVK82

b)

Nature of the transaction

Grant of nil cost option over Ordinary Shares of £0.0005 each under the Softcat plc Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.00

66,864

d)

Aggregated information

Aggregated volume

Price

 

N/A

e)

Date of the transaction

 

2018-04-04

f)

Place of the transaction

 

Outside a trading venue

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZMGGDKKGGRZM
Date   Source Headline
4th Oct 202112:00 pmRNSNotice of Results
1st Oct 20211:04 pmRNSTotal Voting Rights
9th Sep 20213:40 pmRNSDirector/PDMR Shareholding
10th Aug 20214:37 pmRNSDirector/PDMR Shareholding
9th Jul 20212:46 pmRNSDirector/PDMR Shareholding
16th Jun 20213:30 pmRNSBlock Listing Application
9th Jun 202110:09 amRNSDirector/PDMR Shareholding
26th May 20217:00 amRNSQ3 2021 Trading Update
13th May 20212:38 pmRNSBlock listing Interim Review
11th May 202111:19 amRNSDirector/PDMR Shareholding
4th May 202111:00 amRNSTotal Voting Rights
30th Apr 20214:11 pmRNSDirector/PDMR Shareholding
9th Apr 20211:44 pmRNSDirector/PDMR Shareholding
7th Apr 20214:27 pmRNSDirector/PDMR Shareholding
1st Apr 20212:42 pmRNSTotal Voting Rights
25th Mar 20213:42 pmRNSCorrection to Ex-Dividend Date and Record Date
25th Mar 20219:22 amRNSDirector Declaration
24th Mar 20217:00 amRNSHalf-year Report
11th Mar 20212:28 pmRNSDirector/PDMR Shareholding
3rd Mar 20219:20 amRNSDirector Declaration
1st Mar 20214:20 pmRNSTotal Voting Rights
12th Feb 20219:14 amRNSDirector/PDMR Shareholding
1st Feb 202112:07 pmRNSTotal Voting Rights
28th Jan 20213:53 pmRNSDirector/PDMR Shareholding
27th Jan 202111:30 amRNSDirector/PDMR Shareholding
11th Jan 202111:50 amRNSDirector/PDMR Shareholding
11th Jan 20219:20 amRNSDirector Declaration
7th Jan 20211:35 pmRNSDirector/PDMR Shareholding
5th Jan 202111:46 amRNSTotal Voting Rights
5th Jan 20217:00 amRNSTrading Update
11th Dec 20204:14 pmRNSResult of AGM - Correction
10th Dec 20203:02 pmRNSResult of AGM
9th Dec 20203:10 pmRNSDirector/PDMR Shareholding
7th Dec 20202:23 pmRNSDirector/PDMR Shareholding
27th Nov 20203:25 pmRNSDirector/PDMR Shareholding
27th Nov 20202:44 pmRNSDirector/PDMR Shareholding
27th Nov 20202:37 pmRNSDirector/PDMR Shareholding
17th Nov 20204:01 pmRNSHolding(s) in Company
16th Nov 20207:00 amRNSQ1 2021 Trading Update
13th Nov 202011:45 amRNSBlock listing Interim Review
11th Nov 202010:54 amRNSDirector/PDMR Shareholding
11th Nov 20209:27 amRNSDirector Declaration
4th Nov 202012:21 pmRNSAnnual Financial Report - Correction
28th Oct 20201:06 pmRNSAnnual Financial Report and Notice of AGM
20th Oct 20207:00 amRNSFinal Results
13th Oct 20207:00 amRNSDirector/PDMR Shareholding
11th Sep 20207:00 amRNSDirector/PDMR Shareholding
1st Sep 20203:05 pmRNSTotal Voting Rights
19th Aug 20207:00 amRNSFY 2020 Trading Update and Notice of Results
11th Aug 20209:23 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.